Dianthus Therapeutics, Inc. (DNTH)
110.07
-1.03
(-0.93%)
USD |
NASDAQ |
Aug 24, 16:00
110.08
+0.01
(+0.01%)
After-Hours: 20:00
Dianthus Therapeutics Total Assets (Quarterly) : 1.213B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.213B |
| March 31, 2026 | 1.247B |
| December 31, 2025 | 531.40M |
| September 30, 2025 | 577.44M |
| June 30, 2025 | 326.08M |
| March 31, 2025 | 348.58M |
| December 31, 2024 | 374.24M |
| September 30, 2024 | 354.25M |
| June 30, 2024 | 368.96M |
| March 31, 2024 | 382.46M |
| December 31, 2023 | 179.40M |
| September 30, 2023 | 192.46M |
| June 30, 2023 | 78.64M |
| March 31, 2023 | 83.44M |
| December 31, 2022 | 83.11M |
| September 30, 2022 | 164.12M |
| June 30, 2022 | 175.12M |
| March 31, 2022 | 194.38M |
| Date | Value |
|---|---|
| December 31, 2021 | 189.93M |
| September 30, 2021 | 206.24M |
| June 30, 2021 | 220.38M |
| March 31, 2021 | 144.62M |
| December 31, 2020 | 161.62M |
| September 30, 2020 | 174.64M |
| June 30, 2020 | 190.73M |
| March 31, 2020 | 144.44M |
| December 31, 2019 | 161.51M |
| September 30, 2019 | 177.23M |
| June 30, 2019 | 195.44M |
| March 31, 2019 | 147.69M |
| December 31, 2018 | 157.31M |
| September 30, 2018 | 172.79M |
| June 30, 2018 | 180.62M |
| March 31, 2018 | 46.08M |
| December 31, 2017 | 54.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Legend Biotech Corp. | 1.751B |
| Ironwood Pharmaceuticals, Inc. | 285.13M |
| Verastem, Inc. | 206.51M |
| Fortress Biotech, Inc. | 316.72M |
| AbbVie, Inc. | 135.12B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 41.25M |
| Shareholders Equity (Quarterly) | 1.172B |
| Debt to Equity Ratio | 0.0011 |
| Current Ratio | 26.10 |
| Net Debt Paydown Yield | 0.00% |